Silo Pharma's market value is the price at which a share of Silo Pharma trades on a public exchange. It measures the collective expectations of Silo Pharma investors about its performance. Silo Pharma is selling at 0.35 as of the 31st of January 2026; that is 6.06 percent increase since the beginning of the trading day. The stock's open price was 0.33. With this module, you can estimate the performance of a buy and hold strategy of Silo Pharma and determine expected loss or profit from investing in Silo Pharma over a given investment horizon. Check out Silo Pharma Correlation, Silo Pharma Volatility and Silo Pharma Performance module to complement your research on Silo Pharma.
Please note, there is a significant difference between Silo Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Silo Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Meanwhile, Silo Pharma's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Silo Pharma 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Silo Pharma's otc stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Silo Pharma.
0.00
11/02/2025
No Change 0.00
0.0
In 2 months and 31 days
01/31/2026
0.00
If you would invest 0.00 in Silo Pharma on November 2, 2025 and sell it all today you would earn a total of 0.00 from holding Silo Pharma or generate 0.0% return on investment in Silo Pharma over 90 days. Silo Pharma is related to or competes with CNS Pharmaceuticals, Jaguar Animal, GRI Bio, Biodexa Pharmaceticals, Kazia Therapeutics, Can Fite, and Soligenix. Inc., a developmental stage biopharmaceutical company, focuses on merging traditional therapeutics with psychedelic rese... More
Silo Pharma Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Silo Pharma's otc stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Silo Pharma upside and downside potential and time the market with a certain degree of confidence.
Today, many novice investors tend to focus exclusively on investment returns with little concern for Silo Pharma's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Silo Pharma's standard deviation. In reality, there are many statistical measures that can use Silo Pharma historical prices to predict the future Silo Pharma's volatility.
Silo Pharma owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.11, which indicates the firm had a -0.11 % return per unit of risk over the last 3 months. Silo Pharma exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Silo Pharma's Variance of 21.53, risk adjusted performance of (0.12), and Coefficient Of Variation of (583.56) to confirm the risk estimate we provide. The entity has a beta of 2.2, which indicates a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Silo Pharma will likely underperform. At this point, Silo Pharma has a negative expected return of -0.53%. Please make sure to validate Silo Pharma's total risk alpha, skewness, as well as the relationship between the Skewness and day median price , to decide if Silo Pharma performance from the past will be repeated at some point in the near future.
Auto-correlation
0.39
Below average predictability
Silo Pharma has below average predictability. Overlapping area represents the amount of predictability between Silo Pharma time series from 2nd of November 2025 to 17th of December 2025 and 17th of December 2025 to 31st of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Silo Pharma price movement. The serial correlation of 0.39 indicates that just about 39.0% of current Silo Pharma price fluctuation can be explain by its past prices.
Correlation Coefficient
0.39
Spearman Rank Test
0.17
Residual Average
0.0
Price Variance
0.0
Pair Trading with Silo Pharma
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Silo Pharma position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Silo Pharma will appreciate offsetting losses from the drop in the long position's value.
The ability to find closely correlated positions to Silo Pharma could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Silo Pharma when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Silo Pharma - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Silo Pharma to buy it.
The correlation of Silo Pharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Silo Pharma moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Silo Pharma moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Silo Pharma can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Silo Pharma financial ratios help investors to determine whether Silo OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Silo with respect to the benefits of owning Silo Pharma security.